UFP Technologies (NASDAQ:UFPT) Exceeds Q4 Expectations
Medical products company UFP Technologies (NASDAQ:UFPT) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 41.9% year on year to $144.1 million. Its GAAP profit of $2.10 per share was 5.9% above analysts’ consensus estimates.